期刊文献+

他汀类药物治疗高胆固醇血症外的作用 被引量:3

The effects of statins except treating for hypercholesteremia
下载PDF
导出
摘要 他汀类药物是羟甲基戊二酰辅酶A(HMG-CoA)还原酶的竞争性抑制剂,可抑制内源性胆固醇的合成和刺激低密度脂蛋白(LDL)受体的合成,临床上被广泛用来治疗高胆固醇血症。大量的研究发现,他汀类药物除了显著地降低胆固醇、抗动脉粥样硬化和心血管保护作用之外,还具有独立于此之外的其它作用,如肺、肾保护作用、延缓肾衰竭进展、抑制动脉瘤的形成和扩张作用、抗肿瘤作用、促进骨形成作用、促进伤口愈合作用、以及降低感染性休克的死亡风险等多方面的作用。 Statins is known as a cholesterol-lowering agent that inhibits 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and can lower the risk of cardiovascular events by reducing plasma cholesterol levels. Except their treating hypercholesteremia and protection cardiac and vascular function, considerable studies have revealed that statins have effects independent of their cholesterol-lowering effects, refered to as pleiotropic effects. It has been shown that statins also have effects of protecting lung and kidney, preventing the development of renal dysfunction, antitumor activity, playing a role in the management of abdominal aortic aneurysms, promoting bone formation, helping to treat type 2 diabetes-related wound healing disoreders, having the role in altering the host response to bacterial infections and then lowering the risk of death and so on.
出处 《国际内科学杂志》 CAS 2009年第2期106-108,120,共4页 International Journal of Internal Medicine
关键词 他汀类药物 降胆固醇 羟甲基戊二酰辅酶A还原酶抑制剂 Statins Cholesterol-lowering drug Hydroxymethylglutaryl-coenzyme A reductase inhibitors
  • 相关文献

参考文献23

  • 1Mancini GBJ, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coil Cardiol, 2006,47:2554-2560.
  • 2Sukjija R, Bursac Z, Kakar P. et al. Effect of statins on the development of renal dysfunction. Am J Cardiol, 2008,101 : 975 -979.
  • 3Blanco-Colio LM, Martin-Ventura JL, Gomez-Guerrero C, et al. Adiponectin plasma evels are increased by atorvastatin treatment in subjects at high cardiovascular risk. Eur J Pharmacol, 2008, doi:10. 1016/j. e jphar. 2008.02. 042.
  • 4Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol, 2001,21:1712-1719.
  • 5Luan Z, Chase A J, Newby AC. Statins inhibit secretion of metalloproteinases-1 ,-2,-3 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vase Biol, 2003,23:769-775.
  • 6Nagashima H, Aoka Y, Sakomura Y, et al. A 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses prodution of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vase Surg, 2002, 36: 158-163.
  • 7Steinmetz EF, Buckley C, Shames ML, et al. Treatment with simvastatin suppresses the development of experimentalabdominal aortic aneurysms in normal and hypercholesterolemicmice. Ann Surg, 2005,241:92-101.
  • 8Kalyanasundaram A, Elmore JR, Manazer JR, et al. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg, 2006,43 : 117-124.
  • 9Sukhija R, Aronow WS, Sandhu R, et al. Mortality and size of abdominal aortic aneurysm at longterm follow-up of patients not treated surgically and treated with or without statins. Am J Cardiol, 2006,97:279-280.
  • 10Scbouten O, Van Laanen JH, Boersma E, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg, 2006,32:21-26.

同被引文献49

  • 1陈碧珊,苏丽华.他汀类药物的研究进展[J].中国药房,2005,16(7):545-546. 被引量:57
  • 2胡大一,仝其广.全面正确认识他汀的安全问题,积极推动他汀的合理使用(上)——美国脂质学会(NLA)他汀安全性评估工作组报告解读[J].中国医刊,2006,41(10):2-4. 被引量:5
  • 3仝其广,胡大一.他汀类药物的安全性问题[J].中国实用内科杂志,2007,27(9):655-657. 被引量:64
  • 4Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol, 2004, 93(9) :1124-1129.
  • 5Ray JG, Gong Y, Sykora K, et al. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med, 2005, 165(1) :62-67.
  • 6Laufs U, Kilter H, Konkol C, et al. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res, 2002, 53(4):911-920.
  • 7Liao JK. Statin therapy for cardiac hypertrophy and heart failure. J Investig Med, 2004, 52(4):248-253.
  • 8Ramasubbu K, Mann DL. The emerging role of statins in the treatment of heart failure. J Am Coil Cardiol, 2006, 47 (2) :342 -344.
  • 9Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation, 2003, 108 (7) : 839-843.
  • 10Diwan A, Dibbs Z, Nemoto S, et al. Targeted overexpression of noneleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation, 2004, 109(2) :262-268.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部